BBIO vs FOX · rev $221.9M vs P/E 13, rev $16.30B
BridgeBio Pharma Inc (BBIO) versus Fox Corp Class B (FOX) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
BBIO currently screens at market cap $13.24B. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Not investment advice. Open the BBIO and FOX stock pages for the full models.
Not investment advice.